What the InterTAN nail is used for
The InterTAN nail is a cephalomedullary fixation implant used mainly for proximal femur fractures, particularly intertrochanteric fractures between the greater and lesser trochanters. Interest in this device usually comes from clinicians, trainees, procurement teams, and informed readers comparing hip fracture nail designs. The key point is that the InterTAN nail is not simply another intramedullary rod. Its defining feature is an integrated dual-screw construct intended to provide controlled compression and rotational stability in the femoral head and neck segment.
Current evidence suggests potential advantages in implant-related complications compared with some single-screw nails. That finding still needs context. Outcomes depend heavily on fracture pattern, reduction quality, implant position, bone quality, surgeon familiarity, and postoperative care.
In practical terms, the InterTAN system sits within the wider family of intramedullary hip fracture devices. These implants are placed inside the femoral canal, with proximal fixation into the femoral head and neck and distal locking options selected according to nail length and fracture requirements. For broader background on orthopedic fixation topics, this device is best understood as part of the move toward fixation methods that combine minimally invasive access, load sharing, and early mobilization goals.
How the design differs from single-screw cephalomedullary nails
Most cephalomedullary nails follow the same general principle: a nail is inserted through a proximal femoral entry point and secured with one or more head-neck elements. The design difference lies in how the proximal fragment is controlled. Single-screw or blade systems, including commonly discussed PFNA or Gamma-type designs, rely on one main lag screw or helical blade for purchase in the femoral head. The InterTAN nail uses two integrated proximal screws that function as a linked compression and anti-rotation mechanism.
Smith+Nephew professional product information describes the TRIGEN INTERTAN Intertrochanteric Antegrade Nail as using integrated compression screws designed to generate push-pull forces, maintain compression after instrumentation is removed, and address the Z-effect problem seen in some dual-screw systems. The manufacturer also highlights a trapezoidal nail geometry intended to improve metaphyseal fit and place more material laterally, where tensile forces are important. These are design claims and should be read as engineering rationale, not as proof that every patient will achieve a better clinical result.
The design is relevant because intertrochanteric fractures often fail through varus collapse, screw migration, cut-out, rotational displacement, or loss of femoral neck length. An integrated dual-screw construct aims to resist rotation while allowing compression across the fracture. Even so, an implant cannot compensate for poor reduction, an incorrect entry point, unsatisfactory tip-apex distance, or inappropriate case selection. In hip fracture fixation, mechanical advantage and surgical execution are closely linked.
Evidence from guidelines and comparative studies
The most useful way to assess the InterTAN nail is to separate three layers of evidence: regulatory status, guideline-level fracture management, and comparative clinical studies. Each answers a different question. Regulatory records address whether a device can be marketed for stated indications. Guidelines address broad implant classes for fracture patterns. Comparative studies examine whether one implant design performs differently from another in trial or real-world populations.
| Evidence source | What it adds | How to interpret it |
|---|---|---|
| FDA 510(k) records | FDA records for K240061 list the INTERTAN MAX Hip Fracture Nail System with a decision date of September 20, 2024, and indications including several femur fracture categories such as intertrochanteric, subtrochanteric, ipsilateral femoral shaft/neck, and intracapsular fractures. | Clearance supports stated device use but does not prove superiority over another nail in every fracture pattern. |
| AAOS hip fracture guideline context | The AAOS Management of Hip Fractures in Older Adults guideline recommends either a sliding hip screw or cephalomedullary device for stable intertrochanteric fractures, while unstable intertrochanteric, subtrochanteric, and reverse obliquity patterns favor cephalomedullary fixation. | This supports the implant class, not a specific brand or model. |
| 2023 dual-screw versus single-screw meta-analysis | A systematic review and meta-analysis including 23 studies and 3,566 patients reported lower risks of implant failure and revision or reoperation with InterTAN compared with selected single-screw cephalomedullary nails. | The direction is clinically relevant, but the evidence included both randomized and observational studies. |
| 2024 PFNA versus InterTAN meta-analysis | A later meta-analysis found PFNA had shorter operation time, fluoroscopy time, and blood loss, while InterTAN showed advantages in several postoperative complication measures. | This suggests a trade-off rather than a universal winner. |
| 2026 meta-analysis including PFBN | A Journal of Orthopaedics meta-analysis compared PFNA, InterTAN, and newer proximal femoral bionic nail designs across 26 studies and 2,690 patients, suggesting PFBN may perform favorably in some outcomes. | Newer comparisons show that the field is still evolving, and further high-quality studies are needed. |
The evidence does not support the simple claim that the InterTAN nail is always better. A more accurate conclusion is that integrated dual-screw fixation has shown meaningful signals for reducing certain mechanical complications in comparative literature, while other devices may offer shorter operative metrics or similar functional outcomes in selected patients.
Patient and fracture factors that shape implant choice
Implant selection starts with fracture morphology. Stable intertrochanteric fractures may be treated successfully with more than one fixation strategy. Unstable patterns, including reverse obliquity, subtrochanteric extension, comminution of the posteromedial cortex, compromised lateral wall, and displaced lesser trochanter fragments, often strengthen the rationale for a cephalomedullary device. The InterTAN nail may be considered within this cephalomedullary category, especially when rotational control and controlled compression are priorities.
Patient factors are just as important. Older adults with osteoporotic bone present different challenges from younger high-energy trauma patients. Poor bone stock increases concern about fixation purchase and cut-out. Medical comorbidities may make shorter operative time and reduced blood loss more important than small differences in radiographic endpoints. Pre-fracture mobility, cognitive status, anticoagulation, anesthesia risk, and local rehabilitation resources all affect the practical decision.
Surgeon and institution factors also influence implant choice. A device with an additional integrated screw mechanism requires familiarity with instrumentation, drilling sequence, compression technique, and troubleshooting. A team that uses the system frequently may achieve efficient workflows, while a team unfamiliar with it may not realize the theoretical design advantages. The learning curve is not limited to the lead surgeon; it also involves imaging, scrub team setup, implant inventory, and intraoperative decision-making.
Technical factors that still determine success
Even when the implant is appropriate, fixation success depends on several technical principles. The first is fracture reduction. Varus malreduction, posterior sag, excessive distraction, and rotational mismatch can all increase stress on the implant. A strong nail design may delay failure, but it cannot fully neutralize an unfavorable mechanical environment.
The second factor is head-neck element placement. In cephalomedullary fixation, central or inferior-central positioning in the femoral head and an appropriate tip-apex distance are commonly emphasized to reduce cut-out risk. The exact target can vary by implant design and surgeon preference, but the principle is consistent: poor screw or blade placement increases mechanical risk.
The third factor is nail length and distal locking strategy. Short and long cephalomedullary nails both have roles. AAOS guideline materials note that either short or long cephalomedullary nails may be considered for pertrochanteric femur fractures, while the evidence quality for this choice is limited. Long nails may be preferred when there is subtrochanteric extension, shaft involvement, stress riser concern, or other anatomy that needs protection. Short nails may reduce operative time, blood loss, or fluoroscopy in selected cases, but they require careful attention to distal stress and fracture configuration.
The fourth factor is postoperative management. Weight-bearing recommendations vary by fracture stability, reduction quality, fixation strength, bone quality, and surgeon assessment. Early mobilization is a major goal in hip fracture care, but it should not be treated as the same rehabilitation instruction for every patient. Multidisciplinary care, pain control, fall-risk management, osteoporosis assessment, and medical optimization can influence functional recovery as much as the implant itself.
InterTAN versus PFNA and Gamma-type nails
Comparisons between InterTAN, PFNA, and Gamma-type nails usually focus on two issues: mechanical complications and operative burden. The 2023 dual-screw versus single-screw meta-analysis reported that InterTAN was associated with reduced implant failures, hip and thigh pain, and all-cause revision or reoperation compared with the single-screw cephalomedullary nails included in the analysis. Reported risk ratios included 0.37 for implant failure and 0.38 for revision or reoperation, indicating a lower observed risk in the pooled data. See also: Implants.
The 2024 PFNA versus InterTAN meta-analysis shows why these comparisons need balance. PFNA was associated with shorter surgery, less fluoroscopy time, and lower blood loss. InterTAN showed advantages in certain postoperative complications, including shaft fracture, varus collapse, cut-out, screw migration, and hip or thigh pain. Functional outcomes such as Harris Hip Score were described as broadly comparable in that analysis.
For readers evaluating device discussions, the practical interpretation is straightforward: InterTAN may be attractive when mechanical stability and anti-rotation are central concerns. PFNA or other single-screw systems may remain appropriate where operative efficiency, surgeon familiarity, inventory, or patient tolerance is the controlling issue. A comparison table or meta-analysis cannot replace case-specific fracture planning.
Limitations and safety context
Several limitations should temper claims about the InterTAN nail. First, many comparative studies are observational, retrospective, or based on regional practice patterns. These designs can be influenced by selection bias, surgeon experience, fracture classification differences, and follow-up duration. Second, pooled outcomes may combine stable and unstable fractures, short and long nails, and different rehabilitation protocols. Third, newer implants continue to enter the field, so the comparison set is not fixed.
Regulatory and manufacturer documents also have clear boundaries. FDA 510(k) clearance confirms substantial equivalence and stated indications within the U.S. regulatory framework, but it is not the same as a randomized trial showing clinical superiority. Manufacturer product information is useful for understanding design features and intended use, while independent studies are more appropriate for comparative outcome claims.
This article is educational and should not be used as surgical instruction or patient-specific medical advice. Implant choice should be made by qualified orthopedic professionals using imaging, fracture classification, patient risk assessment, institutional resources, and current local regulatory status.
Practical takeaway
The InterTAN nail is best understood as an integrated dual-screw cephalomedullary nail designed to address compression and rotational stability in proximal femur fracture fixation. Evidence from systematic reviews suggests it may reduce some mechanical complications compared with certain single-screw nail designs. It may also involve trade-offs in operative time, fluoroscopy, or blood loss depending on the comparator and clinical setting.
For stable intertrochanteric fractures, multiple fixation strategies can be reasonable. For unstable intertrochanteric, subtrochanteric, or reverse obliquity patterns, cephalomedullary fixation has stronger guideline support. Within that category, the InterTAN nail is an important option, but successful outcomes still rely on reduction, implant positioning, appropriate nail selection, and coordinated postoperative care.
Frequently asked questions
Is the InterTAN nail only used for intertrochanteric fractures?
No. Its best-known use is intertrochanteric hip fracture fixation, but regulatory records for INTERTAN MAX include broader femur fracture indications, such as subtrochanteric and ipsilateral femoral shaft/neck fractures. Actual use depends on the specific system, labeling, surgeon judgment, and regional approval status.
What makes the InterTAN nail different from PFNA?
The main difference is the proximal fixation concept. PFNA uses a helical blade design, while InterTAN uses integrated dual screws intended to combine compression and rotational control. Comparative studies suggest InterTAN may reduce some mechanical complications, while PFNA may have advantages in operative time, fluoroscopy time, and blood loss in some analyses.
Does a dual-screw design prevent cut-out completely?
No. A dual-screw design may reduce the risk in pooled comparative data, but cut-out can still occur. Bone quality, fracture reduction, implant position, tip-apex distance, loading conditions, and patient compliance all influence failure risk.
Is a long InterTAN nail better than a short nail?
Not automatically. Long nails may be useful when the fracture extends subtrochanterically or when the femoral shaft needs additional protection. Short nails may be efficient for selected pertrochanteric patterns. Guidelines indicate that either short or long cephalomedullary nails may be considered for pertrochanteric fractures, with case selection remaining essential.
Can patients choose the InterTAN nail themselves?
Patients can ask informed questions, but implant selection is a surgical decision based on imaging, fracture stability, anatomy, medical risk, device availability, and surgeon experience. The most useful patient discussion is usually about the treatment goal, expected mobilization plan, risks, and follow-up needs rather than choosing a device by brand name.